Area of research
Biomaterials · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Nanoparticle-Based Drug Delivery, Monoclonal and Polyclonal Antibodies Research, Erythrocyte Function and Pathophysiology, and Blood properties and coagulation.
Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications
Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions
Topical nitroglycerin to detect reversible microcirculatory dysfunction in patients with circulatory shock after cardiovascular surgery: an observational study
Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers
Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
Targeting vascular (endothelial) dysfunction
Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1
Vascular Immunotargeting to Endothelial Determinant ICAM-1 Enables Optimal Partnering of Recombinant scFv-Thrombomodulin Fusion with Endogenous Cofactor
Platelet Endothelial Cell Adhesion Molecule Targeted Oxidant-Resistant Mutant Thrombomodulin Fusion Protein with Enhanced Potency In Vitro and In Vivo
Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis
Quantitative analysis of thrombomodulin-mediated conversion of protein C to APC: Translation from in vitro to in vivo